HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying-Fang Zhou Selected Research

CP8816

6/2002Priming effects of novel nonsteroidal progesterone receptor modulators CP8816 and CP8863 on the development of adenomyosis in the mouse uterus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying-Fang Zhou Research Topics

Disease

7Endometriosis
01/2020 - 08/2014
3Adenomyosis
07/2004 - 06/2002
1Neoplasms (Cancer)
01/2020
1Testicular Neoplasms (Testicular Cancer)
01/2019
1Breast Neoplasms (Breast Cancer)
01/2019
1Body Weight (Weight, Body)
07/2004

Drug/Important Bio-Agent (IBA)

4Estrogens (Estrogen)FDA Link
01/2020 - 08/2014
4Aromatase (CYP19)IBA
01/2019 - 09/2015
3Estrogen Receptor betaIBA
01/2020 - 01/2016
3Therapeutic UsesIBA
01/2019 - 08/2014
2Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2015
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2016 - 09/2015
2Dinoprostone (PGE2)FDA Link
11/2015 - 08/2014
1GW 4064IBA
01/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2016
1ProstaglandinsIBA
11/2015
1Estradiol (Delestrogen)FDA LinkGeneric
11/2015
1Phosphotransferases (Kinase)IBA
11/2015
1Estrogen ReceptorsIBA
11/2015
1Metformin (Glucophage)FDA LinkGeneric
08/2014
1Probucol (Lorelco)FDA Link
07/2004
1CholesterolIBA
07/2004
1Phospholipids (Phosphatides)FDA LinkGeneric
07/2004
1Nonesterified Fatty Acids (NEFA)IBA
07/2004
1Triglycerides (Triacylglycerol)IBA
07/2004
1pyrimidineIBA
09/2003
1EnzymesIBA
09/2003
1NucleotidesIBA
09/2003
1O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
09/2003
1Angiogenesis InhibitorsIBA
09/2003
1Progesterone Receptors (Progesterone Receptor)IBA
06/2002
1CP8863IBA
06/2002
1CP8816IBA
06/2002

Therapy/Procedure

1Therapeutics
01/2018